Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000295438 | SCV000400347 | benign | Freeman-Sheldon syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000352771 | SCV000400348 | likely benign | Distal arthrogryposis type 2B1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Labcorp Genetics |
RCV000874040 | SCV001016161 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000874040 | SCV001940032 | benign | not provided | 2020-09-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000874040 | SCV004810995 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | MYH3: BP4 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004800387 | SCV005422875 | uncertain significance | not specified | 2024-10-08 | criteria provided, single submitter | clinical testing | Variant summary: MYH3 c.3731C>T (p.Ala1244Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0008 in 251474 control chromosomes, predominantly at a frequency of 0.0016 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. To our knowledge, no occurrence of c.3731C>T in individuals affected with MYH3-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 321731). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |
Laboratory of Diagnostic Genome Analysis, |
RCV000874040 | SCV001799158 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000874040 | SCV001927518 | likely benign | not provided | no assertion criteria provided | clinical testing |